论文部分内容阅读
骨髓移植是治疗白血病的最好方法。我国每年新增白血病患者4万人,等待着骨髓移植救治的患者有400多万人,而他(她)们的年龄多在35岁以下,其中50％以上是儿童。 骨髓移植的先决条件是为患者寻找白细胞抗原组织配型一致的供者。这种组合的概率在有血缘的兄弟姐妹中为1/4,在非血缘关系人群中仅占1/10万。 目前世界上许多国家建立了骨髓移植资料库。美国库容470万,欧洲570万,日本200多万,台湾也在20万,而我国库容资计不足3万例,与400万患者和13亿人口形成强烈反差。 治疗一个白血病患者,配型相同的供者只需提供少量的健康骨髓造血干细胞,对供者健康不会造成任何影响,且这些细胞可迅速再生,能够用可再生的骨髓来拯救一个生命,还有比这更有意义的事吗?
Bone marrow transplantation is the best way to treat leukemia. There are 40,000 newly-increased leukemia patients each year in China, and more than 4 million patients are waiting for bone marrow transplants. However, most of them are under the age of 35, and more than 50% of them are children. Prerequisites for bone marrow transplantation are for patients looking for donors with uniform tissue matching for leukocyte antigens. The probability of this combination is 1/4 in siblings with blood, and only 1 in 100,000 in non-blood relationships. At present, many countries in the world have established a bone marrow transplantation database. The United States has 4.7 million in capacity, 5.7 million in Europe, more than 2 million in Japan, and 200,000 in Taiwan, and China has less than 30,000 fund-raising capacity, which contrasts sharply with 4 million patients and 1.3 billion people. For the treatment of a leukemia patient, donors with the same type of donor need only provide a small amount of healthy bone marrow hematopoietic stem cells without any impact on the health of the donor. These cells can be quickly regenerated and can use a regenerable bone marrow to save a life. Is there something more meaningful than this?